NeuroOne Medical Technologies Corporation — Cash Flow (NASDAQ:NMTC) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -3.43 M-8.6 M-7.52 M-12.89 M-11.01 M-2.84 M -6.16 M Cash from investing activities -122.43 K-67.08 K-3.24 M2.65 M-120.2 K-81.74 K -98.08 K Cash from financing activities 7.32 M11.53 M12.02 M7.4 M7.27 M8.03 M 8.69 M Free cash flow -3.55 M-8.67 M-7.79 M-13.27 M-11.13 M-2.92 M -6.2 M

新闻

Best Momentum Stocks to Buy for January 6th

New Strong Buy Stocks for January 6th

NeuroOne任命Penumbra高管Jason Mills加入董事会

NeuroOne appoints Penumbra executive Jason Mills to board

Neuroone MedicalQ1每股收益及营收超出预期

Neuroone Medical earnings beat, revenue topped estimates

NeuroOne 2025财年第四季度收入激增，股价上涨

Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises

NeuroOne Medical Technologies获得纳斯达克延期以重新符合最低竞价要求

NeuroOne Medical Technologies receives Nasdaq extension to regain minimum bid price compliance

NeuroOne获得180天延期以重新符合纳斯达克合规要求

NeuroOne receives 180-day extension to regain nasdaq compliance